References
- Lopez-Molina JA, Rivera MJ, Trujillo M, Burdio F, Lequerica JL, Hornero F, et al. Assessment of hyperbolic heat transfer equation in theoretical modeling for radiofrequency heating techniques. Open Biomed Eng J 2008;2:22–7
- Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Ierace T, Solbiati L, et al. Hepatocellular carcinoma: Radio–frequency ablation of medium and large lesions. Radiology 2000;214:761–8
- Iversen H, Lenz S, Dueholm M. Ultrasound-guided radiofrequency ablation of symptomatic uterine fibroids: Short-term evaluation of effect of treatment on quality of life and symptom severity. Ultrasound Obstet Gynecol 2012;40:445–51
- Quinn SD, Gedroyc WM. Thermal ablative treatment of uterine fibroids. Int J Hyperthermia 2015;31:272–9
- Luo X, Shen Y, Song WX, Chen PW, Xie XM, Wang XY. Pathologic evaluation of uterine leiomyoma treated with radiofrequency ablation. Int J Gynaecol Obstet 2007;99:9–13
- Li Y, Ma X, Wu X, Liu X, Liu L. Prognostic significance of survivin in breast cancer: Meta-analysis. Breast J 2014;20:514–24
- Zhang LQ, Wang J, Jiang F, Xu L, Liu FY, Yin R. Prognostic value of survivin in patients with non-small cell lung carcinoma: A systematic review with meta-analysis. PLoS One 2012;7:e34100
- Gasowska-Bodnar A, Bodnar L, Dabek A, Cichowicz M, Jerzak M, Cierniak S, et al. Survivin expression as a prognostic factor in patients with epithelial ovarian cancer or primary peritoneal cancer treated with neoadjuvant chemotherapy. Int J Gynecol Cancer 2014;24:687–96
- Seror O. Ablative therapies: Advantages and disadvantages of radiofrequency, cryotherapy, microwave and electroporation methods, or how to choose the right method for an individual patient? Diagn Interv Imaging 2015;96:617–24
- Xie B, Zhang C, Xiong C, He J, Huang G, Zhang L. High intensity focused ultrasound ablation for submucosal fibroids: A comparison between type I and type II. Int J Hyperthermia 2015;31:593–9
- Yin G, Zhu T, Li J, Chen M, Yang S, Zhao X. Decreased expression of survivin, estrogen and progesterone receptors in endometrial tissues after radiofrequency treatment of dysfunctional uterine bleeding. World J Surg Oncol 2012;10:100
- Yin G, Chen M, Yang S, Li J, Zhu T, Zhao X. Treatment of uterine myomas by radiofrequency thermal ablation: A 10-year retrospective cohort study. Reprod Sci 2014;22:609–14
- Jones S, O’Donovan P, Toub D. Radiofrequency ablation for treatment of symptomatic uterine fibroids. Obstet Gynecol Int 2012;2012:194839
- Oeda S, Mizuta T, Isoda H, Kuwashiro T, Iwane S, Takahashi H, et al. Survival advantage of radiofrequency ablation for hepatocellular carcinoma: Comparison with ethanol injection. Hepatogastroenterology 2013;60(126):1399–404
- Kim YS, Seol CH, Jung JW, Oh SJ, Hwang KE, Kim HJ, et al. Synergistic effect of sulindac and simvastatin on apoptosis in lung cancer A549 cells through AKT-dependent downregulation of survivin. Cancer Res Treat 2015;47:90–100
- Cao XQ, Lu HS, Zhang L, Chen LL, Gan MF. MEKK3 and survivin expression in cervical cancer: Association with clinicopathological factors and prognosis. Asian Pac J Cancer Prev 2014;15:5271–6
- Brunner A, Riss P, Heinze G, Brustmann H. pHH3 and survivin are co-expressed in high-risk endometrial cancer and are prognostic relevant. Br J Cancer 2012;107:84–90
- Kusku CF, Yigit S, Demir L, Cakalagaoglu F, Tarhan O. Correlation of survivin and MMP9 expressions with prognosis and clinicopathological parameters in surface epithelial ovarian carcinomas. Turk Patoloji Derg 2014;30:30–7
- Fest S, Brachwitz N, Schumacher A, Zenclussen ML, Khan F, Wafula PO, et al. Supporting the hypothesis of pregnancy as a tumor: Survivin is upregulated in normal pregnant mice and participates in human trophoblast proliferation. Am J Reprod Immunol 2008;59:75–83
- Lamp M, Saare M, Kadastik U, Karro H, Salumets A, Uibo R, et al. Survivin promoter polymorphisms and autoantibodies in endometriosis. J Reprod Immunol 2012;96:95–100